First Trust Capital Management’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

First Trust Capital Management’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-45,000	Closed	-$453K	–	465
2022 Q2	$453K	Hold	45,000	–	–	0.03%	329
2022 Q1	$453K	Hold	45,000	–	–	0.05%	186
2021 Q4	$454K	Buy	+45,000	New	+$455K	0.08%	174

Other funds holding PBAXU

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $46.4M AUM 13.94% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

First Trust Capital Management's PBAXU Position: Q3 2022 in Review

First Trust Capital Management sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q3 2022, closing a stake of 45,000 shares — an estimated $453K sold.

First Trust Capital Management first reported a position in PBAXU in Q4 2021 and held it in 3 quarters. The position peaked at $454K in Q4 2021. 21 funds tracked by Wall St. Rank hold PBAXU as of Q3 2022.

First Trust Capital Management reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
First Trust Capital Management sold 45,000 Phoenix Biotech Acquisition Corp. Unit shares in Q3 2022, an estimated $453K.
First Trust Capital Management first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 3 quarters.
First Trust Capital Management's Phoenix Biotech Acquisition Corp. Unit position peaked at $454K in Q4 2021.
21 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q3 2022.

Based on First Trust Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.